Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novo Integrated Sciences Inc (NQ: NVOS )

0.6425 -0.0375 (-5.51%)
Streaming Delayed Price Updated: 10:00 AM EDT, Apr 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 191,644
Open 0.6800
Bid (Size) 0.6425 (1)
Ask (Size) 0.6500 (1)
Prev. Close 0.6800
Today's Range 0.6312 - 0.6800
52wk Range 0.0690 - 2.230
Shares Outstanding 19,054,523
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
NVOS Stock Earnings: Novo Integrated Sciences Reported Results for Q2 2024
Novo Integrated Sciences just reported results for the second quarter of 2024. 
Via InvestorPlace
Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results
From Novo Integrated Sciences, Inc.
Via Business Wire

Performance

YTD
-16.62%
-16.62%
1 Month
+32.78%
+32.78%
3 Month
-18.95%
-18.95%
6 Month
+147.50%
+147.50%
1 Year
+363.23%
+363.23%

More News

Read More
Novo Integrated Sciences Closes on $6,210,000 Securities Purchase Agreement
From Novo Integrated Sciences, Inc.
Via Business Wire
Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Novo Integrated Sciences Provides Update on Certain Current Actions and Events
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Subsidiary, Clinical Consultants International, Signs Agreement with Futura Surgicare Pvt Ltd.
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Receives Limited Waiver to Securities Purchase Agreement for $70,000,000 Promissory Note
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Appoints New President
From Novo Integrated Sciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Novo Integrated Sciences Reports Fiscal Year 2024 First Quarter Financial Results
From Novo Integrated Sciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Blacksheep Trust Files Partial Assignment of $1 Billion Dollar Gold Backed Bond to Novo Integrated Sciences
From Novo Integrated Sciences, Inc.
Via Business Wire
NVOS Stock Earnings: Novo Integrated Sciences Reported Results for Q4 2023
Via InvestorPlace
Novo Integrated Sciences Reports 2023 Fiscal Year Financial Results
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Signs Master Collaboration Agreement with Psychocare Health Pvt. Ltd. India
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences’ Purchase and Sale Agreement to Acquire Ophir Collection Receives Court Approval
From Novo Integrated Sciences, Inc.
Via Business Wire
Why Novo Integrated Sciences (NVOS) Stock Is Getting Obliterated
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Toast Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Novo Integrated Sciences Announces Reverse Stock Split
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Advised Receipt of Proceeds of RC Consulting Promissory Note Expected in 3-5 Business Days
From Novo Integrated Sciences, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.